Led by Editor-in-Chief Hana El-Samad, PhD, GEN Biotechnology is the new peer-reviewed journal from Mary Ann Liebert, Inc. and Genetic Engineering & Biotechnology News (GEN) delivering exceptional research breakthroughs, news, and analysis directly impacting biotech. Launched in 2022, the journal provides a dynamic forum aimed at unifying both traditional academic audiences and executives and researchers from across the industry. Submit your manuscript today!
Company Details
- Founded
- 2021
- Address
- New Rochelle, New York, Us
- Industry
- Book And Periodical Publishing
- NAICS
-
Publishing Industries (except Internet)Newspaper, Periodical, Book, and Directory PublishersDirectory and Mailing List PublishersOther PublishersGreeting Card PublishersAll Other Publishers
- Website
- http://www.liebertpub.com/genbio
- Keywords
- biotechnology, journals, peer-reviewed research, genome editing, cell therapy, drug discovery, big data, immunotherapy, neuroscience, cancer research, translational research, precision medicine, single-cell biology, agbiotech.
- HQ
- New Rochelle, New York
Gen Biotechnology Questions
Gen Biotechnology's website is http://www.liebertpub.com/genbio
Gen Biotechnology's LinkedIn profile is https://www.linkedin.com/company/gen-biotechnology
Gen Biotechnology's industry is
Book and Periodical Publishing
Gen Biotechnology's top competitors are
Rapport Therapeutics,
Ts Ventures Fund,
Porras Tmi Lab,
Arteriosclerosis, Thrombosis, And Vascular Biology (Atvb),
Breakthrough Montessori Public Charter School,
Tdm Health,
Orox Biosciences,
Syntato,
Spring Care Pas,
Exozymes (Nasdaq: Exoz).
Gen Biotechnology's categories are Book and Periodical Publishing
Gen Biotechnology's founding year is 2021
